News Releases
Recent and archived press releases with clinical and research news
-
October 18, 2024
Curbing late-stage breast cancer diagnosis: Innovative mobile diagnostic kit aims to improve early detection in Uganda
An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage. -
October 18, 2024
All of Us tour stops at VUMC Oct. 22-25
The All of Us Research Program brings the future of health to VUMC and Nashville. -
October 16, 2024
Study seeks to improve brain health in children with Type 1 diabetes
Children with Type 1 diabetes are at increased risk for neurocognitive complications. Vanderbilt University Medical Center has been selected as one of 11 clinical centers in the United States to evaluate children newly diagnosed with Type 1 diabetes for neurocognitive outcomes. -
October 15, 2024
MEGAMicrobe event for children set for Saturday, Oct. 26
The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways. -
October 8, 2024
Vanderbilt Health Rx Solutions introduces service to bridge gap between health systems and pharmaceutical manufacturers
The new consulting service will offer robust capabilities in understanding the provider journey, prescription journey, data capabilities and best practice sharing. -
October 8, 2024
Monroe Carell Jr. Children’s Hospital at Vanderbilt again ranked among nation’s best
Monroe Carell has made the Best Children’s Hospitals list for 18 consecutive years, every year since the ranking’s inception in 2007. -
October 7, 2024
New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage
Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.